Oragenics, Inc. OGEN
0.49
(0.01)
(2.00%)
as of 25 Sep
- Market cap
- $2.3M
- P/E
- 0.4×
Follow OGEN
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
P/S ratio |
— | — | 123.16 | 66.13 | 60.08 | — | — | — | — | — |
P/FCF ratio |
— | — | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
P/Operating CF |
— | — | (13.82) | (5.94) | (21.09) | — | — | — | — | — |
P/B ratio |
— | — | 9.67 | 1.27 | 2.20 | — | — | — | — | — |
Price to Tangible BV |
— | — | 9.67 | 1.27 | 2.20 | — | — | — | — | — |
EV/Sales |
— | — | 95.53 | 14.54 | 29.17 | — | — | — | — | — |
EV/EBITDA |
— | — | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
— | — | (1.62) | (0.21) | (1.89) | — | — | — | — | — |
EV/FCF |
— | — | (1.63) | (0.21) | (1.88) | — | — | — | — | — |
Quick Ratio |
4.73 | 0.51 | 1.94 | 7.16 | 18.87 | 13.14 | 9.87 | 17.31 | 6.86 | 3.04 |
Current Ratio |
5.64 | 0.87 | 2.15 | 8.95 | 19.17 | 13.40 | 10.18 | 18.78 | 8.01 | 3.14 |
Net Debt/EBITDA |
0.98 | 0.08 | 0.17 | 0.79 | 1.73 | 0.66 | 1.16 | 2.03 | 0.93 | 0.48 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.94 | 0.81 | 0.35 | 1.07 | 0.86 | 0.64 | 0.84 | 0.80 | 0.95 | 0.83 |
Capex/Depreciation |
0.00 | — | (34.17) | (2.58) | (1.07) | 0.00 | (0.40) | (4.14) | 0.00 | (0.33) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (243.94%) | (1,550.11%) | (317.98%) | (81.08%) | (93.80%) | (259.28%) | (122.09%) | (153.18%) | (452.93%) | (220.80%) | |
| (170.58%) | (328.26%) | (209.44%) | (66.47%) | (66.98%) | (137.54%) | (74.47%) | (77.41%) | (116.83%) | (168.47%) | |
ROIC |
0.00% | 0.00% | 0.00% | (569.54%) | 0.00% | 0.00% | 0.00% | (927.17%) | (2,795.56%) | 0.00% |
Return on Tangible Assets |
(118.85%) | 4,987.21% | (999.02%) | (111.50%) | (59.72%) | (158.43%) | (91.14%) | (54.24%) | (106.57%) | (286.51%) |
Average Days of Receivables |
0.00 | — | 0.00 | 0.00 | 29.37 | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 41,089.12% | 7,659.85% | 12,167.93% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 14,461.54% | 3,406.54% | 6,059.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 2,697.08% | 564.41% | 1,940.23% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | 0.14 | 0.87 | 0.50 | — | — | — | — | — |
Graham Number |
— | — | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Earnings Yield |
— | — | (136.57%) | (95.46%) | (31.08%) | — | — | — | — | — |
Free Cash Flow Yield |
— | — | (47.71%) | (106.18%) | (25.81%) | — | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.50 | 1.97 | 1.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(4.29) | (38.90) | (97.34) | (227.63) | (208.19) | (539.90) | (553.74) | (1,243.81) | (2,357.00) | (2,830.04) |
Capex per Share |
0.00 | 0.00 | (12.50) | (1.73) | (0.68) | 0.00 | (1.07) | (17.08) | 0.00 | (10.00) |
Free Cash Flow per Share |
(4.29) | (38.90) | (109.84) | (229.36) | (208.87) | (539.90) | (554.81) | (1,260.89) | (2,357.00) | (2,840.04) |
Cash per Share |
3.89 | 3.91 | 46.51 | 170.80 | 421.42 | 561.77 | 777.36 | 2,768.26 | 2,283.74 | 1,632.24 |
Shareholders Equity per Share |
3.84 | (0.96) | 42.30 | 194.46 | 409.37 | 536.45 | 733.26 | 2,860.55 | 2,339.37 | 1,186.28 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.84 | (0.96) | 42.30 | 194.46 | 409.37 | 536.45 | 733.26 | 2,860.55 | 2,339.37 | 1,186.28 |
Free Cash Flow |
(9.25) | (8.60) | (8.23) | (15.34) | (13.51) | (16.95) | (13.04) | (9.20) | (6.36) | (7.10) |
Working Capital |
8.28 | (0.21) | 2.07 | 12.69 | 26.26 | 16.64 | 16.99 | 20.77 | 6.29 | 2.88 |
Capital Expenditures |
— | — | (0.94) | (0.12) | (0.04) | — | (0.03) | (0.12) | — | (0.02) |
Net Current Asset Value |
8.28 | (0.21) | 2.07 | 12.54 | 25.96 | 16.15 | 16.32 | 20.77 | 6.29 | 2.88 |
EV/EBIT |
— | — | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
— | — | 24.84 | 0.88 | 0.50 | — | 0.00 | 0.00 | — | 0.00 |
Net Profit Margin |
0.00% | 0.00% | (54,789.66%) | (10,865.70%) | (18,059.31%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
— | — | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | — | 0.00 | 0.37 | 0.90 | 1.21 | 0.68 | 0.26 | 3.03 | 0.86 |
Cash ROIC |
(55.43%) | (1,316.80%) | (109.61%) | (62.82%) | (25.14%) | (49.29%) | (36.92%) | (22.38%) | (51.16%) | (101.65%) |
Accounts Receivable Turnover |
0.00 | — | 0.00 | 0.00 | 7.70 | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.03 | — | — | — | 0.01 | — | — | — | — | — |
Average Payables |
1.46 | 1.42 | 1.30 | 1.04 | 0.94 | 1.24 | 1.29 | 0.93 | 1.05 | 1.05 |
Average Assets |
5.77 | 3.22 | 9.86 | 21.49 | 23.46 | 19.22 | 20.90 | 14.63 | 5.76 | 5.04 |
Average Common Equity |
4.03 | 0.68 | 6.50 | 17.62 | 16.75 | 10.19 | 12.75 | 7.39 | 1.49 | 3.85 |
Columns are period end dates